Editor’s Note
Effective with the October issue, Diagnostic Testing & Technology Report is now Diagnostic Testing & Emerging Technologies. Our new name reflects an increasing emphasis on emerging technologies and trends in in vitro diagnostics. We will continue to bring you the latest on new tests, analysis of critical developments affecting test manufacturers, and details on mergers, […]
Effective with the October issue, Diagnostic Testing & Technology Report is now Diagnostic Testing & Emerging Technologies. Our new name reflects an increasing emphasis on emerging technologies and trends in in vitro diagnostics. We will continue to bring you the latest on new tests, analysis of critical developments affecting test manufacturers, and details on mergers, acquisitions, and alliances impacting the diagnostics industry. Please send comments to Kimberly Scott, managing editor of G2 Intelligence, at kscott@G2Intelligence.com.
This content is exclusive to Diagnostic Testing and Emerging Technologies subscribers
Start a Free Trial for immediate access to this article and our entire archive of over 20 years of DTET reports.
This content is exclusive to Diagnostic Testing and Emerging Technologies subscribers
Start a Free Trial for immediate access to this article and our entire archive of over 20 years of DTET reports.